2002-2018年安大略省和不列颠哥伦比亚省儿童及成人侵袭性肺炎球菌疾病的基于人群发病率:加拿大免疫研究网络(CIRN)研究
该研究在加拿大安大略省和不列颠哥伦比亚省建立27,525人的队列,结合监测数据与健康行政数据库估计侵袭性肺炎球菌疾病(IPD)负担。安大略省年龄和性别调整后年发病率从13.7/10万(2005年)至13.6/10万(2018年)相对稳定,不列颠哥伦比亚省从10.9/10万(2002年)上升至13.2/10万(2018年)。2007-2018年PCV7血清型和额外PCV13血清型发病率下降,而独特PPV23和非疫苗血清型发病率上升。
要点
- 安大略省年龄和性别调整后IPD年发病率从13.7/10万(2005年)至13.6/10万(2018年)相对稳定。
- 不列颠哥伦比亚省IPD年发病率从10.9/10万(2002年)上升至13.2/10万(2018年)。
- 2007-2018年两省PCV7和额外PCV13血清型发病率下降,独特PPV23和非疫苗血清型上升。
核心结论
- 尽管有公共资助的肺炎球菌疫苗接种规划,IPD在加拿大仍造成重大公共卫生负担,部分原因是独特PPV23和非疫苗血清型增加。
研究设计与样本
- 在安大略省和不列颠哥伦比亚省建立27,525人的队列,结合监测数据与健康行政数据库,使用泊松回归模型估计年龄和性别调整的年发病率和PCV/PPV血清型特异性IPD发病率。
主要发现
- 安大略省共识别20,205例IPD病例,包括15,299例实验室确诊病例,年龄和性别调整后年发病率从13.7/10万(2005年)至13.6/10万(2018年)相对稳定。
- 不列颠哥伦比亚省共识别7,320例IPD病例,包括5,932例实验室确诊病例,年发病率从10.9/10万(2002年)上升至13.2/10万(2018年)。
- 年龄≥85岁的老年人发病率最高。
- 2007-2018年两省PCV7血清型和额外PCV13血清型发病率下降,而独特PPV23和非疫苗血清型发病率上升。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive pneumococcal disease (IPD) burden, evaluated in Canada using reported confirmed cases in surveillance systems, is likely underestimated due to underreporting. We estimated the burden of IPD in Ontario and British Columbia (BC) by combining surveillance data with health administrative databases. METHODS: We established a cohort of 27,525 individuals in Ontario and BC. Laboratory-confirmed IPD cases were identified from Ontario's integrated Public Health Information System and the BC Centre for Disease Control Public Health Laboratory. Possible IPD cases were identified from hospitalization data in both provinces, and from emergency department visit data in Ontario. We estimated the age and sex adjusted annual incidence of IPD and pneumococcal conjugate/polysaccharide vaccine (PCV/PPV) serotype-specific IPD using Poisson regression models. RESULTS: In Ontario, 20,205 overall IPD cases, including 15,299 laboratory-confirmed cases, were identified with relatively stable age- and sex-adjusted annual incidence rates ranging from 13.7/100,000 (2005) to 13.6/100,000 (2018). In BC, 7,320 overall IPD cases, including 5,932 laboratory-confirmed cases were identified; annual incidence rates increased from 10.9/100,000 (2002) to 13.2/100,000 (2018). Older adults aged ≥ 85 years had the highest incidence rates. During 2007-2018 the incidence of PCV7 serotypes and additional PCV13 serotypes decreased while the incidence of unique PPV23 and non-vaccine serotypes increased in both provinces. CONCLUSIONS: IPD continues to cause a substantial public health burden in Canada despite publicly funded pneumococcal vaccination programs, resulting in part from an increase in unique PPV23 and non-vaccine serotypes.
引用
- Nasreen S, Wang J, Kwong JC, et al. Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) study. Vaccine. 2021. PMID: 34810001. doi:10.1016/j.vaccine.2021.11.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。